What do research ethics committees say about applications to do cancer trials?

The Lancet Oncology

Volumn 9, Issue 8, 2008, Pages 700-701

  Dixon Woods, Mary ^a   Angell, Emma ^a   Tarrant, Carolyn ^a   Thomas, Anne ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; CONFIDENTIALITY; DATA BASE; EUROPEAN UNION; GOOD CLINICAL PRACTICE; HUMAN; INFORMED CONSENT; LETTER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; ONCOLOGY; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS;

CLINICAL TRIALS AS TOPIC; DRUGS, INVESTIGATIONAL; ETHICS COMMITTEES, RESEARCH; EUROPEAN UNION; FEMALE; GREAT BRITAIN; HUMANS; INFORMED CONSENT; MALE; NEOPLASMS; PATIENT SELECTION;

EID: 47849088233     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70184-0     Document Type: Letter

References (5)

1. UK NHS. Management information (2007), UK NHS, London. http://www.nres.npsa.nhs.uk/news-and-publications/publications/corporate-publications/management-information/ (accessed July 6, 2008).
2. Duley L., Antman K., Arena J., et al. Specific barriers to the conduct of randomized trials. Clin Trials 5 (2008) 40-48
3. Sheard L., Tompkins C., Wright N., and Adams C. Non-commercial trials of a medicinal product: can they survive the current process of research approvals in the UK?. J Med Ethics 32 (2006) 430-434
4. Angell E., Jackson C., Ashcroft R., Bryman A., Windridge K., and Dixon-Woods M. Is 'inconsistency' in research ethics committee decision-making really a problem? An empirical investigation and reflection. Clin Ethics 2 (2007) 92-99
5. Jefford M., and Moore R. Improvement of informed consent and quality of consent documents. Lancet Oncol 9 (2008) 485-493